References
- The Guardian, Court orders “miracle” drug treatment. 7 December 2006, p 4
- High Court Citation 3128 (Family Division) 6th December 2006. Bansley PCT v J. Potter M
- Gill-Thwaites H. The sensory modality assessment and rehabilitation technique—a tool for assessment and treatment of patients with severe brain damage in a vegetative state. Brain Injury 1997; 11: 723–734
- Kertesz A. Western aphasia battery. Harcourt Brace Jovanovich Inc, New York 1982
- Clauss RP, Guldenpfennig WM, Nel HW, Sathekge MM, Venkannagen RR. Extraordinary arousal from semi comatose state on zolpidem: a case report. South African Medical Journal 2000; 90: 68–72
- Clauss RP, van der Merwe CE, Nel HW. Arousal from a semi-comatose state on zolpidem. South African Medical Journal 2001; 91: 788–789
- Clauss RP, Nel HW. Drug induced arousal from PVS. Neurorehabilitation 2006; 21: 23–28
- Clauss RP, Nel HW. The effect of zolpidem on brain injury and diaschisis as detected by 99mTc HMPAO Brain SPECT in humans. Arzneimittel-Forschung/Drug Research 2004; 54: 641–646
- Garretto NS, Bueri JA, Rey RD. Improvement of blephorospasm with Zolpidem. Movement Disorders 2004; 19: 967–968
- Cohen L, Chaaban B, Haberl MO. Transient improvement of aphasia with zolpidem. New England Journal of Medicine 2004; 350: 949–950
- Clauss RP, Sathekge MM, Nel HW. Transient improvement of Spinocerebellar Ataxia with Zolpidem. New England Journal of Medicine 2004; 351: 511–512
- Feldman RS, Meyer JS, Quenzer LF. Principles of neuropsychopharmacology. Sunderland, ConneticutUSA 1997; 417, Sinauer Associates
- Mastain B, Vaiva G, Guerouaou D, Pommery J, Thomas P. Favourable effect of zolpidem on catatonia [Article in French]. Review Neurologique 1995; 151: 52–56
- Mastain B, Rascle C, Thomas P, Goudemand M. Zolpidem in catatonic syndrome: from pharmacological test to a pathophysiological hypothesis. Movement Disorders 1998; 13: 46
- Rudolph U, Crestani F, Moehler H. GABA(A) receptor subtypes: dissecting their pharmacological functions. Trends in Pharmacology Science 2001; 22: 188–194
- Kang-Park MH, Wilson WA, Moore SD. Differential actions of diazepam and zolpidem in basolateral and central amygdala nuclei. Neuropharmacology 2004; 46: 1–9
- Crestani F, Martin J, Moehler H, Rudolph U. Mechanism of action of the hypnotic zolpidem in vivo. British Journal of Pharmacology 2000; 131: 1251–1254
- Sanger DJ, Griebel G, Perrault G. Discriminative stimulus effects of drugs acting at GABA (A) receptors: differential profiles and receptor selectivity. Pharmacology and Biochemistry of Behavior 1999; 64: 269–273
- Enna SJ, Stern LZ, Wastek GJ. Cerebrospinal fluid gamma-aminobutyric acid variations in neurological disorders. Archives of Neurology 1977; 34: 683–685
- Palmer AM, Marion DW, Botscheller ML. Increased transmitter amino acid concentration in human CSF after brain trauma. Neuroreport 1994; 6: 153–156